Annual EBITDA
$2.72B$403.63M+17.39%
Summary
- Current Value
- As of today, DVA annual EBITDA is $2.72B, up +17.39% on
- Historical Performance
- DVA annual EBITDA is up +9.67% over the past 3 years, and up +20.86% over the past 5 years
- All-Time High Comparison
- DVA annual EBITDA is currently -1.19% below its historical high of $2.76B set on
- 3-Year Low Comparison
- DVA annual EBITDA is +32.53% above its 3-year low of $2.06B reached on an earlier date
- Sector Comparison
- DVA annual EBITDA is higher than 96.60% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $2.72B | +17.4% | +9.7% | +20.9% | +132.3% | |
| Quarterly EBITDA | $673.10M | -6.3% | +35.2% | +14.3% | +114.8% | |
| TTM EBITDA | $2.64B | +0.5% | +22.5% | +10.6% | +119.7% | |
| Price | $104.74 | -36.5% | +32.5% | -11.8% | +194.2% | |
| PE Ratio | 10.78 | -29.7% | -23.1% | -42.1% | -40.5% | |
| Annual Revenue | $12.82B | +5.6% | +10.3% | +12.5% | +109.8% | |
| Annual EPS | $10.73 | +44.6% | +20.6% | +103.5% | +428.5% | |
| Annual EBIT | $2.00B | +27.0% | +10.9% | +22.1% | +112.0% | |
| Annual Net Income | $1.25B | +30.7% | +3.2% | +36.6% | +160.7% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.72B | at high | |
| 5Y | $2.72B | at high | |
| All | $2.76B | -1.2% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $2.06B | N/A | +32.5% |
| 5Y | $2.06B | +32.5% | |
| All | $21.90M | >+9999.0% |
EBITDA History
FAQ
What is the current annual EBITDA of DVA?
As of today, DVA annual EBITDA is $2.72B
What is 1-year change in DVA annual EBITDA?
DVA annual EBITDA is up +17.39% year-over-year
What is 3-year change in DVA annual EBITDA?
DVA annual EBITDA is up +9.67% over the past 3 years
How far is DVA annual EBITDA from its all-time high?
DVA annual EBITDA is currently -1.19% below its historical high of $2.76B set on December 31, 2016
How does DVA annual EBITDA rank versus sector peers?
DVA annual EBITDA is higher than 96.60% of companies in Healthcare sector
When is DVA next annual earnings release?
The next annual earnings release for DVA is on
Quarterly EBITDA
$673.10M$32.09M-4.55%
Summary
- Current Value
- As of today, DVA quarterly EBITDA is $673.10M, down -4.55% on
- Historical Performance
- DVA quarterly EBITDA is down -6.28% year-over-year, and up +35.24% over the past 3 years
- All-Time High Comparison
- DVA quarterly EBITDA is currently -6.28% below its historical high of $718.18M set on
- 3-Year Low Comparison
- DVA quarterly EBITDA is +50.08% above its 3-year low of $448.50M reached on an earlier date
- Sector Comparison
- DVA quarterly EBITDA is higher than 95.84% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $673.10M | -4.5% | -6.3% | +35.2% | +14.3% | |
| Annual EBITDA | $2.72B | – | +17.4% | +9.7% | +20.9% | |
| TTM EBITDA | $2.64B | -1.7% | +0.5% | +22.5% | +10.6% | |
| Price | $104.74 | -16.4% | -36.5% | +32.5% | -11.8% | |
| PE Ratio | 10.78 | -16.4% | -29.7% | -23.1% | -42.1% | |
| Quarterly Revenue | $3.42B | +1.2% | +4.8% | +16.0% | +17.0% | |
| Quarterly EPS | $2.04 | -20.9% | -18.6% | +80.4% | +59.2% | |
| Quarterly EBIT | $495.61M | -6.6% | -6.7% | +63.4% | +14.7% | |
| Quarterly Net Income | $240.25M | -12.7% | -18.8% | +45.9% | +10.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $705.18M | -4.5% | |
| 3Y | $718.18M | -6.3% | |
| 5Y | $718.18M | -6.3% | |
| All | $718.18M | -6.3% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $609.78M | +10.4% | |
| 3Y | $448.50M | N/A | +50.1% |
| 5Y | $448.50M | +50.1% | |
| All | -$57.00M | +1280.9% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of DVA?
As of today, DVA quarterly EBITDA is $673.10M
What is DVA quarterly EBITDA most recent change?
DVA quarterly EBITDA was down -4.55% on September 30, 2025
What is 1-year change in DVA quarterly EBITDA?
DVA quarterly EBITDA is down -6.28% year-over-year
How far is DVA quarterly EBITDA from its all-time high?
DVA quarterly EBITDA is currently -6.28% below its historical high of $718.18M set on September 30, 2024
How does DVA quarterly EBITDA rank versus sector peers?
DVA quarterly EBITDA is higher than 95.84% of companies in Healthcare sector
When is DVA next earnings release?
The next earnings release for DVA is on
TTM EBITDA
$2.64B$45.09M-1.68%
Summary
- Current Value
- As of today, DVA TTM EBITDA is $2.64B, down -1.68% on
- Historical Performance
- DVA TTM EBITDA is up +0.50% year-over-year, and up +22.49% over the past 3 years
- All-Time High Comparison
- DVA TTM EBITDA is currently -1.68% below its historical high of $2.69B set on
- 3-Year Low Comparison
- DVA TTM EBITDA is +31.51% above its 3-year low of $2.01B reached on
- Sector Comparison
- DVA TTM EBITDA is higher than 96.11% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $2.64B | -1.7% | +0.5% | +22.5% | +10.6% | |
| Annual EBITDA | $2.72B | – | +17.4% | +9.7% | +20.9% | |
| Quarterly EBITDA | $673.10M | -4.5% | -6.3% | +35.2% | +14.3% | |
| Price | $104.74 | -16.4% | -36.5% | +32.5% | -11.8% | |
| PE Ratio | 10.78 | -16.4% | -29.7% | -23.1% | -42.1% | |
| TTM Revenue | $13.32B | +1.2% | +5.1% | +14.4% | +15.4% | |
| TTM EPS | $9.71 | -4.6% | +4.7% | +42.2% | +47.4% | |
| TTM EBIT | $1.94B | -1.8% | +2.9% | +34.3% | +10.1% | |
| TTM Net Income | $1.10B | -4.8% | -3.1% | +21.3% | +4.4% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.69B | -1.7% | |
| 3Y | $2.69B | -1.7% | |
| 5Y | $2.69B | -1.7% | |
| All | $2.69B | -1.7% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.64B | at low | |
| 3Y | $2.01B | +31.5% | |
| 5Y | $2.01B | +31.5% | |
| All | -$25.40M | >+9999.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of DVA?
As of today, DVA TTM EBITDA is $2.64B
What is DVA TTM EBITDA most recent change?
DVA TTM EBITDA was down -1.68% on September 30, 2025
What is 1-year change in DVA TTM EBITDA?
DVA TTM EBITDA is up +0.50% year-over-year
How far is DVA TTM EBITDA from its all-time high?
DVA TTM EBITDA is currently -1.68% below its historical high of $2.69B set on June 30, 2025
How does DVA TTM EBITDA rank versus sector peers?
DVA TTM EBITDA is higher than 96.11% of companies in Healthcare sector
When is DVA next earnings release?
The next earnings release for DVA is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- DVA Official Website www.davita.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/927066/000092706625000165/0000927066-25-000165-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/927066/000092706625000012/0000927066-25-000012-index.htm
- DVA Profile on Yahoo Finance finance.yahoo.com/quote/DVA
- DVA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dva